Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Magenta Therapeutics Inc (MGTA)

Magenta Therapeutics Inc (MGTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 449,240
  • Shares Outstanding, K 39,338
  • Annual Sales, $ 0 K
  • Annual Income, $ -57,520 K
  • 60-Month Beta 3.15
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.53
  • Number of Estimates 4
  • High Estimate -0.47
  • Low Estimate -0.55
  • Prior Year -0.49
  • Growth Rate Est. (year over year) -8.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.54 +19.71%
on 09/10/19
12.65 -9.72%
on 08/14/19
-0.38 (-3.22%)
since 08/13/19
3-Month
9.54 +19.71%
on 09/10/19
16.87 -32.31%
on 06/24/19
-3.24 (-22.10%)
since 06/13/19
52-Week
5.31 +115.07%
on 12/28/18
21.00 -45.62%
on 03/26/19
-0.58 (-4.83%)
since 09/13/18

Most Recent Stories

More News
Magenta Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today...

MGTA : 11.42 (+1.51%)
JPM : 120.23 (+1.97%)
Magenta Therapeutics Announces Pricing of Public Offering

Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today...

MGTA : 11.42 (+1.51%)
JPM : 120.23 (+1.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft.

See More Share

Trade MGTA with:

Business Summary

Magenta Therapeutics Inc. is a clinical-stage biotechnology company. It engaged in developing therapeutics focused on critical areas of unmet need in the field of bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. Magenta Therapeutics Inc. is headquartered...

See More

Key Turning Points

2nd Resistance Point 12.43
1st Resistance Point 11.93
Last Price 11.42
1st Support Level 10.75
2nd Support Level 10.08

See More

52-Week High 21.00
Fibonacci 61.8% 15.01
Fibonacci 50% 13.15
Last Price 11.42
Fibonacci 38.2% 11.30
52-Week Low 5.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar